Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Mike Hickey

This Could Be One of the Best Gen AI Stocks to Buy for 2026, According to Wall Street

Wall Street believes AppLovin has emerged as a standout GenAI contender for 2026, fueled by strong AI-led performance gains.

Barchart

“When it came out, all we got was indifference and accusations that we’d sold out. Now it’s worshipped”: The brutal story of Carcass’s early 90s death metal classic Heartwork

Hash pipes, bust-ups and a death metal landmark – how Carcass made 1993’s classic Heartwork album

Metal Hammer

FanDuel owner Flutter lists in New York amid US gambling boom

Gambling giant hails America as its ‘natural home’ and proposes primary listing in New York as US sports betting business surges

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Roblox Stock a Buy Near Its Low?

Metaverse pioneer Roblox Corporation’s (RBLX) slow growth and declining daily active users are concerning. Moreover, the stock is currently trading near its 52-week low. So, will it be wise to invest in the stock now? Read more to find out….

StockNews.com

Here's Why Roblox's February Metrices Disappointed Benchmark

Roblox Corp (NYSE:RBLX) disclosed key metrics for February 2022. Roblox's daily active users climbed 28% year on year to 55.1 million. Roblox's hours engaged rose 21% Y/Y to 3.8 billion. Roblox's booking estimate were $203 million - $206 million, down 2% - 4% Y/Y. Roblox's average booking per daily active user estimate declined…

Benzinga

Here's Why Take-Two Interactive Software Shares Are Trading Higher Today

Take-Two Interactive Software Inc's (NASDAQ:TTWO) Rockstar Games said a new game in the Grand Theft Auto series is developing. The studio also announced the release of Grand Theft Auto V on the newest consoles, the PlayStation 5 and Xbox Series X, for March 15. Analyst Ratings: Jefferies analyst Andrew Uerkwitz reiterated a Buy rating and $231 price…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.